麗珠集團(000513.SZ):2024年公司境外收入爲17.24億元,佔總營收約14.59%
格隆匯7月2日丨麗珠集團(000513.SZ)在互動平臺表示,歐盟是公司重要的境外市場之一,公司產品已在多個歐盟國家實現銷售收入。2024年公司境外收入爲17.24億元,佔總營收約14.59%,該境外收入包含來自歐盟地區國家的貢獻。根據上市規則,關於歐盟市場的具體銷售收入及佔總收入的比例等細項數據未達到單獨披露的標準,相關業務進展可參閱公司定期報告。公司將持續致力於拓展國際市場,優化佈局,提升全球競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.